About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,360 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,360 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1861-1880 of 11,360 trials

CompletedPRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-TransplantThis is a pilot/feasibility, multicenter, randomized, open label, clinical trial to test that hypothesis that plasmapheresis plus rituximab prior to or at the time of kidney…NCT03763643·Tuscaloosa, Alabama and 11 others CompletedStudy Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing SpondylitisThis was a study estimating the clinical difference between 300 mg and 150 mg of secukinumab following dose escalation to 300 mg in patients with ankylosing spondylitisNCT03350815·Jonesboro, Arkansas and 64 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

CompletedA Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)This study includes two periods.NCT03104400·Huntsville, Alabama and 344 others

CompletedZonisamide SR Plus Bupropion SR Combination Therapy in Subjects With ObesityThe purpose of this study is determine if the combination of zonisamide SR and bupropion SR are is more effective than either drug given alone or placebo in the treatment of…NCT00709371·Fairhope, Alabama and 19 others

CompletedStudy to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell LiposarcomaThis trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors. This trial is a sub study of the Master study NCT03967223.NCT05993299·Duarte, California and 37 others

RecruitingSubcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.NCT06598306·Los Angeles, California and 30 others

CompletedVortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionThe purpose of this study is to evaluate the effects of Vortioxetine (Lu AA21004), once daily (QD), compared with escitalopram on sexual functioning.NCT01364649·Birmingham, Alabama and 61 others

CompletedAmputee Residual Limb Volume FluctuationThe goal of this project is a useful clinical instrument for diagnosis and treatment of residual limb volume fluctuation in individuals who use prosthetic limbs.NCT01161238·Seattle, Washington

TerminatedBeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia BThe BeCoMe-9 Study (BE-101-01) is a Phase 1/2, first in human, multi-center, open-label, dose-escalation study to evaluate the safety and clinical activity of a single intravenous…NCT06611436·Davis, California and 4 others

CompletedCyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeThis trial is studying the side effects and how well giving cyclophosphamide and busulfan followed by donor stem cell transplant works in treating patients with myelofibrosis…NCT00445744·Seattle, Washington

CompletedLong-Term Safety Of PF-00547659 In Ulcerative ColitisSubjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 144 weeks of open-label treatment to evaluate the long-term…NCT01771809·Scottsdale, Arizona and 98 others

Active not recruitingBrentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin LymphomaThis phase III trial studies brentuximab vedotin and combination chemotherapy to see how well they work compared to combination chemotherapy alone in treating children and young…NCT02166463·Birmingham, Alabama and 198 others

CompletedA Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and LymphomaPatients with relapsed or refractory leukemia often develop resistance to chemotherapy and some patients who relapse following CD19 directed therapy relapse with CD19 negative…NCT03244306·Seattle, Washington

Active not recruitingA Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsThe purpose of this study is to evaluate efficacy of erdafitinib versus chemotherapy or pembrolizumab in participants with advanced urothelial cancer harboring selected fibroblast…NCT03390504·Anchorage, Alaska and 344 others

CompletedS9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.NCT00003784·Mobile, Alabama and 86 others

CompletedA Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese SubjectsThe purpose of this study is to determine whether the combination of naltrexone SR and bupropion SR is safe and effective in the treatment of obesity.NCT00567255·Phoenix, Arizona and 35 others

CompletedS0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaRATIONALE: Monoclonal antibodies, such as epratuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00945815·Little Rock, Arkansas and 80 others

TerminatedStudy of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)1. Part A: Subjects will receive Patritumab or placebo with erlotinib.NCT02134015·Glendale, Arizona and 97 others

CompletedPALISADE Follow-on Study (ARC004)The purpose of this study is to demonstrate the safety, tolerability, and efficacy of AR101 through oral immunotherapy (OIT) in peanut-allergic children and adults who have…NCT02993107·Tucson, Arizona and 64 others

CompletedRegistry of Patients Treated With Systemic Mold-Active TriazolesThe purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection…NCT03066011·Birmingham, Alabama and 55 others

PreviousPage 94 of 568Next

in Seattle

Heart Diseasein Seattle